Nikolaos Papadopoulos is Professor of Allergy and Pediatric Allergy at the University of Athens (NKUA), Greece, and at the University of Manchester, UK. He has extensive clinical and educational experience in Paediatric Allergy, having headed for many years a unit caring for more than 7000 children with allergic diseases yearly, implementing state-of-the-art interventions and training medical students, resident paediatricians and allergists. His research focus is the interphase between infection and allergic disease, with emphasis in asthma exacerbations and food allergy. He is the Co-ordinator of the EU-funded project CURE. He has extensive collaborations in the context of EU Projects, such as PreDicta, GA2LEN, EUROPREVALL, iFAAM and FAST. Prof Papadopoulos has published over 300 papers (h-index: 81), has received several international awards and is invited to speak at international scientific meetings some 30 times a year. Moreover, he has/is serving in Boards of EAACI, GA2LEN, WAO, EFA and ARIA. He was the 2013-2015 President of EAACI and the 2017 - 2019 President of the Respiratory Effectiveness Group.